BD Diagnostics announced that it has received clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver from the FDA for nasopharyngeal swab specimens on the BD Veritor System for Rapid Detection of Respiratory Syncytial Virus (RSV). It is the first CLIA-waived RSV test system with a digital result to be offered commercially.
The RSV test, when used with the BD Veritor System Reader, incorporates Advanced Nano-particle and Adaptive Read technologies to obtain an accurate result while showing results on a hand held reader with an easy-to-read digital display. Test results are available in approximately 10 minutes.
The BD Veritor System is currently cleared for use in physician offices, hospitals, and other patient-care settings.
For more information call (800) 638-8663 or visit BD.com.